The new data comes from the phase 3 ALLEVIATE-1 trial, which compared cebranopadol to placebo for the management of ...

HB 241 would require health insurers to cover physical therapy, acupuncture, massage therapy, and chiropractic care as ...

Even if pain medications would incur a risk of hastening death, Jewish law permits – and even mandates – administering the ...

Revolutionary medical treatments offer new hope for chronic pain sufferers through advanced technology, targeted medications ...

There are many different treatment options available ... Carefully consider how you use pain relievers and all medications. It is easy to overmedicate yourself. Check with your doctor before ...

As opioid pain medications continue being prescribed for chronic and severe pain, understanding their risks becomes ...

Strides Pharma Science's Singapore arm receives USFDA approval for its generic Acetaminophen and Ibuprofen tablets, offering ...

Tris Pharma has pointed to a phase 3 win for its pain relief drug as demonstrating the candidate’s potential to help resolve the opioid crisis. | Tris Pharma has pointed to a phase 3 win for its pain ...

The Food and Drug Administration (FDA) hasn’t approved any medications containing CBD for pain relief, and additional research is necessary to determine CBD’s ability to reduce pain ...

Strides Pharma Science Ltd announced that its subsidiary, Strides Pharma Global Pte. Limited in Singapore, has received USFDA ...

Researchers didn’t recommend it as a stand-alone treatment for acute migraine pain. Naproxen can better alleviate acute migraine pain when combined with other drugs. For example, taking naproxen ...